Clinical Trials on TB - Tuberculosis HIV in Spain

Total 610 results

Sociedad Andaluza de Enfermedades Infecciosas

Completed

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

HIV Infections

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

HIV Infections | Tuberculosis

Spain
Hospital Mutua de Terrassa
Institut Català de la Salut; Hospital Vall d'Hebron; Public Health Agency of... and other collaborators

Unknown

Tuberculosis In Children Visiting Friends and Relatives

Tuberculosis Infection

Spain
Germans Trias i Pujol Hospital
Archivel Farma S.L.

Completed

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Tuberculosis | Latent Tuberculosis Infection

Spain
Tuberculosis Network European Trialsgroup

Unknown

New Generation IGRA in Immunocompromised Individuals (TBnet#54)

Active Tuberculosis | Monitoring, Immunologic | Tuberculosis in Solid Organ Transplant Recipients | Tuberculosis in Marrow Transplant Recipients | Tuberculosis in Rheumatoid Arthritis | Tuberculosis in Chronic Renal Failure | Tuberculosis in HIV-infected Individuals

Denmark, Germany, Italy, Moldova, Republic of, Norway, Poland, Portugal, Romania, Spain, United Kingdom
Germans Trias i Pujol Hospital
Fondo de Investigacion Sanitaria

Unknown

Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection (HYPDYN)

Latent Tuberculosis Infection

Spain
Hospital Universitari de Bellvitge
Cellestis

Completed

QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (OPTIMIST)

Latent Tuberculosis Infection

Spain
Hospital Virgen de la Luz

Terminated

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

Tuberculosis

Spain
Germans Trias i Pujol Hospital
CIBERES CRP-TB program

Unknown

Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner (GRANLATHU)

Tuberculosis

Spain
Fundacion para la Investigacion Biomedica del Hospital...
Instituto de Salud Carlos III

Completed

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) (DRIVE)

HIV Infection | HCV Coinfection

Spain
Juan Macías
Spanish National Health System

Unknown

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

HIV Infection | HCV Coinfection

Spain
Manresana de Micobacteriologia, SL

Completed

Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection

Tuberculosis

Spain
Clinica Universidad de Navarra, Universidad de...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Hyfe...

Recruiting

Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease

Cough | Asthma | Tuberculosis | GERD | COPD | COVID-19 Pneumonia | Non-Tuberculous Mycobacterial Pneumonia

Spain
Fundacion SEIMC-GESIDA
ViiV Healthcare

Completed

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir (FOSTER-C)

HCV Coinfection | Chronic HIV Infection

Spain
Hospital Clinic of Barcelona

Completed

Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients. (RALDAR)

Integrase Inhibitors, HIV; HIV PROTEASE INHIB

Spain
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Terminated

"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". (FLISH-ILT)

Infection in Solid Organ Transplant Recipients | Latent Tuberculosis Infection

Spain
GlaxoSmithKline

Recruiting

A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

Tuberculosis

Spain
Hospital Universitario Infanta Leonor

Completed

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid ((UMC))

HIV Infections | Drug Use | HCV Infection | HBV (Hepatitis B Virus) | Viral Hepatitis

Spain
Fundació Institut Germans Trias i Pujol
Umeå University; North-Western State Medical University named after I.I.Mechnikov and other collaborators

Unknown

Innovation in Tuberculosis (INNOVA4TB)

Tuberculosis

Spain
Manresana de Micobacteriologia, SL

Completed

Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From Tuberculosis

Tuberculosis

Spain
University Hospital Virgen de las Nieves
Instituto de Salud Carlos III

Unknown

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women (9-VPH-MVIH)

HIV Infections | HPV Infection

Spain
Centers for Disease Control and Prevention

Completed

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (iAdhere)

Latent Tuberculosis Infection

United States, China, South Africa, Spain
Fundación Pública Andaluza Progreso y Salud
Gilead Sciences

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." (hEPAtic)

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Spain
Fundació Institut de Recerca de l'Hospital de la...
Hospital Clinic of Barcelona; University of Barcelona

Completed

Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.

HIV-associated Hypertriglyceridemia | HIV-associated Hypercholesterolemia | HIV-associated Inflammatory State

Spain
Hospital Clinic of Barcelona

Completed

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

HIV

Spain
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection (PREVENT TB)

Tuberculosis

United States, Canada, Spain, Brazil
Hospital Universitari Vall d'Hebron Research Institute
Gilead Sciences

Completed

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

HIV-1

Spain
Hospital Universitari Vall d'Hebron Research Institute
University Hospital, Ghent; IrsiCaixa

Completed

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

HIV-1

Spain
Gilead Sciences

Completed

Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada (RECOMB)

HIV-1

Spain
Hospital Clinic of Barcelona

Unknown

Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV

Hiv

Spain
Fundacion Clinic per a la Recerca Biomédica

Completed

Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open. (STRIB-PEP)

HIV

Spain
Anna Cruceta

Completed

Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine (A-TRI-WEEK)

HIV

Spain
Fundación Pública Andaluza para la gestión de la...

Not yet recruiting

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Hiv

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Irs...

Completed

Drug Interactions Between Silimarine and Darunavir/Ritonavir

HIV

Spain
Fundació Institut Germans Trias i Pujol
Germans Trias i Pujol Hospital; Hospital del Mar; Hospital Sant Joan de Deu; Hospital... and other collaborators

Recruiting

Design of an Integrative Algorithm for Staging Tuberculosis (STAGE-TB)

Tuberculosis

Spain
Fundacion SEIMC-GESIDA

Completed

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients (CIDAN12)

HIV

Spain
Juan A. Arnaiz

Completed

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

HIV-1

Spain
Fundacion para la Investigacion Biomedica del Hospital...
Pfizer

Completed

Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1

HIV-1

Spain
Germans Trias i Pujol Hospital

Completed

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

HIV

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Drug Interactions Between Echinacea Purpurea and Etravirine

HIV

Spain
Elza Aparecida Machado Domingues

Completed

Pharmacotherapy Follow-up in Older HIV-infected Patients

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat (GHB_Cobi)

HIV | Pharmacokinetic Interactions

Spain
David Garcia Cinca
Dr. Josep Mallolas

Unknown

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study (DORAVIPEP)

Hiv

Spain, France
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (RALAM-RollOver)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (RALAM-II)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Effects of ART Simplification on Inflammatory Markers in coRis (AIR) (AIR)

HIV

Spain
Eva Bonfill

Recruiting

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection (DASAHIVCURE)

Recent HIV-1 Infection

Spain
Juan Macías

Completed

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection (STERAL)

HIV Infection | HCV Coinfection

Spain
Hospital General Universitario Gregorio Marañon
University of California, Los Angeles; Fundación para la Investigación Biomédica... and other collaborators

Unknown

Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected (MIAMI)

HIV-1-infection

Spain

Clinical Trials on TB - Tuberculosis HIV in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations